Human recombinant B7-H3 (from HEK293)
Lieferant: ACRO Biosystems
Zertifikate
Über diesen Artikel
Spezifikationen
- Konjugation:Unconjugated
- Protein/Peptid-Typ:Rekombinant
- Ursprung:HEK293 cells
- Spezies:Human
- Lagerbedingungen:–20 °C
- Endotoxingehalt:Less than 1,0 EU per μg by the LAL method.
- Biologische Aktivität:Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human B7-H3, His Tag at 2 μg/ml (100 μl/well) can bind Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 with a linear range of 0,3-5 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilised Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 at 2 μg/ml (100 μl/well) can bind Human B7-H3, His Tag with a linear range of 0,01-0,156 μg/ml (Routinely tested).; Human B7-H3, His Tag inhibits Anti-CD3-induced proliferation of PBMC. The EC50 for this effect is 2,24-3,36 μg/ml (Routinely tested)
- Gen-ID:Q5ZPR3-2
- Frei von Trägern:Y
- Frei von Proteasen:Y
- Tierfrei:Y
- Proteinsynonym:B7 homolog 3|B7-H3|CD276
- Protein/Peptid-Name:B7-H3
- Purity:>95%
- Molecular weight:25,2 kDa
- Endotoxinspiegel:Low
- Zusammensetzung:Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation
- Frei von Nukleasen:Y
- Transporttemperatur:Powder,RT
Spezifikationen
Frequently Bought Together